Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration

CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanized monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months

Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights

IDT's library prep solutions join Illumina's extensive software ecosystem to enable streamlined analysis for IDT's FFPE and cfDNA workflows.

ClearNote Health Secures $52 Million in Series D Financing and Strengthens Leadership Team to Accelerate Growth in Early Cancer Detection

ClearNote Health today announced a $52M Series D financing alongside the appointment of Kevin Keegan as President and COO.

CellCarta and Sonic Healthcare Establish Strategic Partnership to Commercialize Companion Diagnostics Through Lab Network

CellCarta has announced a Strategic Partnership with Sonic to launch the first commercial laboratory relationship in CellCarta’s Lab Network strategy.

Baptist Health South Florida and The START Center for Cancer Research Announce Strategic Partnership to Expand Patient Access to Early-Phase Cancer Trials

New START site to be established in collaboration with Baptist Health Herbert Wertheim Cancer Institute will bring novel oncology therapies closer to patients across South Florida.

Syncell Launches High-Precision Proteomics Discovery Service Powered by Microscoop® Mint Platform

Syncell announced the commercial launch of Syncell Discovery Services, a new sample-to-discovery offering that gives biopharma, translational, and academic researchers direct access to insights generated by the company’s unbiased nanoscopic Microscoop Mint platform.

‘Biopharma innovators must widen CDMO networks to accelerate development’ says Shilpa Biologicals CEO ahead of BIO San Diego

Ahead of BIO San Diego, Shilpa Biologicals urges biotech innovators to engage CDMO partners earlier and look beyond large-scale providers. Over-relying on a narrow network of large CDMOs increases the risk of scope creep, severe clinical trial delays, and budget overruns of up to 40%. Conversely, incorporating smaller CDMOs can lower costs and accelerate timelines from discovery to clinic by several months.

Biopharma PEG Highlights High-Purity DSPE-PEG Derivatives for Advanced Nanocarrier Drug Delivery Systems

Quotient Sciences Advances AI-Designed Drug Product into Clinical Development

Ambience Healthcare Expands Chart-Aware Intelligence to Full Inpatient Workflow

Building on its chart awareness platform, Ambience now delivers clinical context across the full hospital stay, from admission through discharge

Ardena appoints Ariane de Ganck as Chief Scientific Officer

Pfizer and Innovent Biologics Enter $10.5 Billion Oncology Drug Development Partnership for 12 Cancer Programs

Pfizer and Innovent Biologics have signed an oncology partnership worth up to $10.5 billion to develop a pipeline of 12 cancer programs focused on antibody-drug conjugates (ADCs) and multispecific antibodies. Pfizer will pay $650 million upfront, with additional milestone-based payments tied to development and commercialization success. The collaboration combines Innovent’s early-stage research capabilities with Pfizer’s global development and commercialization expertise to accelerate the delivery of new cancer therapies worldwide.

Leica Biosystems and CellCarta Expand Collaborative Companion Diagnostic Development Model to Accelerate Commercialization Globally

CellCarta and Leica Biosystems have announced a strategic partnership to bring a proven companion diagnostic (CDx) joint development model from China to biopharma sponsors globally.

Neuland reports record quarterly revenue of $83M* driven by commercial NCE projects

Quarterly revenue growth up 135% year-on-year, with total revenues passing ₹2000 crore for the first time

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

Life Sciences Industry Veteran Appointed to Lead Global Commercial Organization

University of Manchester techbio spin-out secures £5 million to deploy quantum physics, AI modelling, and highly automated labs to power next gen enzyme engineering

£5 million seed funding round by PXN Ventures, with additional funding from existing investors IQ Capital and Northern Gritstone Company uses quantum physics, AI modelling and deeply integrated laboratory automation and robotics in a closed loop system to engineer enzymes, transforming their performance for industries including pharmaceutical manufacturing, personal care and sustainable chemical production Work with a Fortune 500 personal care company delivering over 670x improvements in enzyme performance Guy Levy-Yurista joins as CEO to spearhead growth in closed loop AI-guided enzyme engineering

Yourgene Health Launches Insight DPYD Assay

Enhanced pharmacogenetic workflow includes additional variants to support safer, personalised chemotherapy treatment for cancer patients

Cytiva introduces next-generation Biacore 8 series SPR systems for faster, more confident drug discovery

Atrandi Biosciences Expands Leadership Team to Accelerate Global Adoption of Capsule-Based Single-Cell Technology

Atrandi announced the appointments of Sam Ropp as Chief Commercial Officer and Susan Tousi as Chairman of the Board. These additions strengthen Atrandi’s leadership team as the company accelerates global adoption of its single-cell multiomic SPC technology.

NGI Becomes First Certified Core Lab and Service Provider for Epigenica’s EpiFinder™ Platforms

Epigenica AB has announced an agreement with the National Genomics Infrastructure, one of the largest technical platforms at SciLifeLab.